LFB
Live / Registered — Registered — partial invalidation of extension of protection (as of 19 Feb 2025)
What this means for you
Registered since 11 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79220430
- Registration number
- 5557831
- Mark type
- Stylized text
- Filed
- 29 Aug 2017
- Published for opposition
- 26 Jun 2018
- Registered
- 11 Sept 2018
- Attorney of record
- James R. Davis, II
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products and preparations for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care; medicines for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care [ ; diagnostic products for medical and veterinary use for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care ]
- Class 009 — Scientific and electric apparatus: [ Scientific apparatus and instruments, namely, diagnostic apparatus and instruments for calculating and managing drug penetration parameters, for assessing immune deficiency, for laboratory use; downloadable electronic and digital publications, namely, magazines, newsletters, brochures, articles in the field of health; ] downloadable instructional and teaching material, namely, software in the field of health; [ electronic reports featuring results from clinical trials and studies in the field of health; ] recorded software, namely, software for providing medical information in the field of immunology, haemostasis, intensive care, immune deficiency; computer software for educational and commercial activities, namely, software providing information in the field of health; software applications used with medical diagnostic apparatus to calculate and manage immune deficiency or bleeding; computer software for Websites, Intranet and the Internet, namely, software for training and information of patients and health professionals; downloadable computer software applications in the field of health for calculating and managing drug penetration parameters in the human body
- Class 010 — Medical apparatus: [ Medical, veterinary, surgical apparatus and instruments, namely, diagnostic apparatus and instruments in the nature of apparatus for medical diagnostic testing and screening in the field of immunology, haemostasis, intensive care, immune deficiency; apparatus for analysis and diagnosis of disorders or diseases in the field of immunology, haemostasis, intensive care, immune deficiency; medical devices, namely, blood collection kits, disposable cartridge, diagnostic kits consisting primarily of probes, buffers and reagents for use in blood coagulation testing and screening ]
- Class 035 — Advertising and business services: [ Retail store services featuring pharmaceutical preparations and products, and medical devices; wholesale retail store services featuring pharmaceutical preparations and products, and medical devices; import and export agencies in the field of pharmaceutical preparations and products, and medical devices; commercial representation, namely, promoting the goods and services of others; sales promotion ]
- Class 041 — Education and entertainment services: [ Editing and publishing of texts other than advertising texts in the field of health; arranging and providing education, training and instruction, namely, providing classes, seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops in the field of health; organization and conducting of seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops, in the field of health ]
- Class 042 — Scientific and technological services: [ Scientific and technological services as well as research and design services relating thereto, namely, scientific research, product development, design and testing for new product and engineering in the field of health; industrial analysis and research services in the field of health; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines; conducting scientific studies in the field of immunology, haemostasis, intensive care; research and development of new products for others; scientific research for medical purposes in the field of immunology, haemostasis, intensive care; cellular and molecular biology research; testing of pharmaceutical products; conducting clinical trials for others in the field of immunology, haemostasis, intensive care; engineering; ] advice and assistance in the field of health
- Class 044 — Medical, beauty and agricultural services: [ Medical analysis relating to human blood plasma; ] sampling, collection and preservation of human blood plasma; providing advice and information in the field of health
Owner
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, LES ULIS, FR
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, F-91940 LES ULIS, FR
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, F-91940 LES ULIS, FR
Prosecution history
- 19 Oct 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 20 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 19 Feb 2025 — REGISTERED - PARTIAL SEC 71 ACCEPTED
- 18 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Sept 2024 — TEAS SECTION 71 RECEIVED
- 04 May 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Sept 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Apr 2021 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 09 Apr 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 03 Apr 2021 — CORRECTION TRANSACTION RECEIVED FROM IB